These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 29183097

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
    Malviya M, Ohlsson A, Shah S.
    Cochrane Database Syst Rev; 2008 Jan 23; (1):CD003951. PubMed ID: 18254035
    [Abstract] [Full Text] [Related]

  • 3. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
    Malviya M, Ohlsson A, Shah S.
    Cochrane Database Syst Rev; 2003 Jan 23; (3):CD003951. PubMed ID: 12917997
    [Abstract] [Full Text] [Related]

  • 4. Treatment of patent ductus arteriosus and neonatal mortality/morbidities: adjustment for treatment selection bias.
    Mirea L, Sankaran K, Seshia M, Ohlsson A, Allen AC, Aziz K, Lee SK, Shah PS, Canadian Neonatal Network.
    J Pediatr; 2012 Oct 23; 161(4):689-94.e1. PubMed ID: 22703954
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes.
    Laughon M, Bose C, Clark R.
    J Perinatol; 2007 Mar 23; 27(3):164-70. PubMed ID: 17251985
    [Abstract] [Full Text] [Related]

  • 7. CYP2C9*2 is associated with indomethacin treatment failure for patent ductus arteriosus.
    Rooney SR, Shelton EL, Aka I, Shaffer CM, Clyman RI, Dagle JM, Ryckman K, Lewis TR, Reese J, Van Driest SL, Kannankeril PJ.
    Pharmacogenomics; 2019 Aug 23; 20(13):939-946. PubMed ID: 31486736
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. B-type natriuretic peptide predicts responses to indomethacin in premature neonates with patent ductus arteriosus.
    Hsu JH, Yang SN, Chen HL, Tseng HI, Dai ZK, Wu JR.
    J Pediatr; 2010 Jul 23; 157(1):79-84. PubMed ID: 20227723
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Predictors of failed closure of patent ductus arteriosus with indomethacin.
    Boo NY, Mohd-Amin I, Bilkis AA, Yong-Junina F.
    Singapore Med J; 2006 Sep 23; 47(9):763-8. PubMed ID: 16924357
    [Abstract] [Full Text] [Related]

  • 14. [Is it possible to predict the success of pharmacological closure of persistent ductus arteriosus in prematurely born neonates?].
    Fendler W, Bernas S, Jarosik K, Piotrowski A.
    Anestezjol Intens Ter; 2008 Sep 23; 40(3):156-61. PubMed ID: 19469116
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Patent ductus arteriosus management and outcomes in Japan and Canada: comparison of proactive and selective approaches.
    Isayama T, Mirea L, Mori R, Kusuda S, Fujimura M, Lee SK, Shah PS, Neonatal Research Network of Japan and the Canadian Neonatal Network.
    Am J Perinatol; 2015 Sep 23; 32(11):1087-94. PubMed ID: 25825965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.